Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 123,080 | 191,581 | 71,821 | 53,695 | 35,965 |
| Marketable Securities | 262,293 | 238,536 | 278,983 | 300,970 | 354,939 |
| Receivables | 40,765 | 12,195 | 9,007 | 7,089 | 6,851 |
| TOTAL | $431,876 | $448,681 | $367,350 | $372,420 | $406,835 |
| Non-Current Assets | |||||
| PPE Net | 1,849 | 1,728 | 1,833 | 1,954 | 2,098 |
| Investments And Advances | 35,470 | 27,914 | 42,646 | 15,473 | 27,026 |
| Other Non-Current Assets | 14,639 | 15,095 | 15,547 | 15,988 | 16,430 |
| TOTAL | $51,958 | $44,737 | $60,026 | $33,415 | $45,554 |
| Total Assets | $483,834 | $493,418 | $427,376 | $405,835 | $452,389 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,002 | 3,592 | 4,890 | 4,582 | 4,698 |
| Accrued Expenses | 39,501 | 38,401 | 33,680 | 25,903 | 30,967 |
| TOTAL | $45,428 | $43,880 | $40,420 | $32,298 | $37,442 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 367,538 | 365,171 | 377,077 | 325,759 | 326,844 |
| TOTAL | $367,538 | $365,171 | $377,077 | $325,759 | $326,844 |
| Total Liabilities | $412,966 | $409,051 | $417,497 | $358,057 | $364,286 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,667 | 30,429 | 27,449 | 27,319 | 26,763 |
| Common Shares | 30 | 30 | 27 | 27 | 27 |
| Retained earnings | -759,327 | -737,543 | -704,692 | -658,032 | -614,096 |
| Other shareholders' equity | 305 | 759 | -415 | -624 | -797 |
| TOTAL | $70,868 | $84,367 | $9,879 | $47,778 | $88,103 |
| Total Liabilities And Equity | $483,834 | $493,418 | $427,376 | $405,835 | $452,389 |